National Institute of Genomic Medicine

National Institute of Genomic Medicine

The National Institute of Genomic Medicine is one of Mexico's twelve national institutes under the Secretariat of Health. The institute was founded in 2004, with its official headquarters built eight years later. INMEGEN is dedicated to the development of genomic medicine for the Mexican population. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for National Institute of Genomic Medicine, Mexico, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

70%


Total
Publications

2.2K


Total Open
Publications

1.5K


Total
Citations

77K


Open Access
Percentage

70%


Total
Publications

2.2K


Total Open
Publications

1.5K


Total
Citations

77K

Wikipedia

Website

download

Breakdown

14% 46% 10% 30%

Publisher Open

14%

Both

46%

Other Platform Open

10%

Closed

30%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220240260Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

65%OA Journal

OA Journal 65%

868

Hybrid 24%

319

No Guarantees 11%

151

Other Platform Open

Domain 83%

1K

Preprint 15%

186

Institution 15%

184

Other Internet 13%

158

Public 11%

139

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
1K
Europe PMC
Domain
408
Semantic Scholar
Public
126
DOI
Other Internet
98
bioRxiv
Preprint
87
Research Square
Preprint
42
University of California - eScholarship University of California
Institution
30
Preprints
Preprint
27
medRxiv
Preprint
23
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
23
1 / 17

Data updated 13 February 2025

Share

Share

Share